Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome

Rheumatology

Volumn 44, Issue 6, 2005, Pages 756-761

  Jiménez, Sònia ^a   García Criado, M Angels ^a   Tàssies, Dolors ^a   Reverter, Joan Carles ^a   Cervera, Ricard ^a   Gilabert, M Rosa ^a   Zambón, Daniel ^a   Ros, Emilio ^a   Bru, Concepció ^a   Font, Josep ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Antiphospholipid syndrome; Atherosclerosis; Carotid ultrasound; Systemic lupus erythematosus

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; TRIACYLGLYCEROL; C REACTIVE PROTEIN;

ADULT; AGING; ANTIPHOSPHOLIPID SYNDROME; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; DISEASE ACTIVITY; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; TUNICA MEDIA; VASCULAR DISEASE; AGE; ARTERIOSCLEROSIS; BLOOD; ERYTHROCYTE SEDIMENTATION RATE; HYPERLIPIDEMIA; MIDDLE AGED;

ADULT; AGE FACTORS; ANTIPHOSPHOLIPID SYNDROME; APOLIPOPROTEINS B; ARTERIOSCLEROSIS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID STENOSIS; CHOLESTEROL; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES; VASCULAR DISEASES;

EID: 24944496938     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keh581     Document Type: Article

References (45)

1. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejía JC et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: A comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308.
2. Urowitz MB, Bookman AM, Koehler BE et al. The bimodal pattern of systemic lupus erythematosus. Am J Med 1970;60:221-5.
3. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: The bimodal pattern revised. QJM 1985;55:87-98.
4. Helve T. Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland. Scand J Rheumatol 1985;14:43-46.
5. Reveille JD, Bartolucci A, Alarcón GS. Prognosis in systemic lupus erythematosus: Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum 1990;33:37-48.
6. Pistiner M, Wallace DJ, Nessim S, Metzger AL, Klinenberg JR. Lupus erythematosus in the 1980s: A survey of 570 patients. Semin Arthritis Rheum 1991;21:55-64.
7. Abu-Shakra M, Urowitz MB, Gladman DD, Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center. I. Causes of death. J Rheumatol 1995;22:259-64.
8. Ward M, Pyun E, Studenski S. Causes of death in systemic lupus erythematosus: Long-term follow-up of an inception cohort. Arthritis Rheum 1995;38:1492-9.
9. Petri M, Perez-Gutthann S, Spence D, Hochberg MC. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992;93:513-9.
10. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;330:973-9.
11. Alexander RW. Inflammation and coronary artery disease. N Engl J Med 1994;331:468-9.
12. Mach F, Shonbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 1998;394:200-3.
13. Vaarala O, Mänttäri M, Manninen V. Anti-cadiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men. Circulation 1995;91:23-7.
14. Wu R, Nityanand S, Berglund L, Lithell H, Holm G, Lefvert AK. Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction. Arterioscler Thromb Vasc Biol 1997;17:3159-63.
15. Puurunen M, Manttari M, Manninen V. Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med 1994;154:2605-9.
16. 2-Glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages. Clin Exp Immunol 1997;107:569-73.
17. Vaarala O, Alfthan O, Jauhiainen M, Leirisalo-Repo M, Aho K, Palosino T. Cross-reaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in SLE. Lancet 1993;342:923-5.
18. Agatston AS, Janowitz WR, Kaplan G, Gasso J, Hildner F, Viamonte M Jr. Ultrafast computed tomography-detected coronary calcium reflects the angiographic extents of coronary arterial atherosclerosis. Am J Cardiol 1994;74:1272-4.
19. Kaufmann RB, Sheedy PF, Maher JE, Bielak LF, Breen JF, Scwartz RS et al. Quantity of coronary artery calcium detected by electron beam computed tomography in asymptomatic subjects and angiographically studied patients. Mayo Clin Proc 1995;70:223-32.
20. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Shwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area. A histopathologic correlative study. Circulation 1995;92:2157-61
21. Mintz GS, Pichard AD, Pompa JJ et al. Determinants and correlates of target lesion calcium in coronary artery disease: A clinical, angiographic and intravascular ultrasound study. J Am Coll Cardiol 1997;29:268-74.
22. Maheer JE, Bielak LF, Raz JA, Sheedy PF, Schwartz RS, Peyser PA. Progression of coronary artery calcification: A pilot study. Mayo Clin Proc 1999;74:347-55.
23. Von Feldt J. Coronary electron beam computed tomography (EBCT) in 13 SLE patients with 2 or more cardiovascular risk factors. Arthritis Rheum 1998;41:S139.
24. Bruce IN, Burns RJ, Gladman DD, Urowitz MB. High prevalence of myocardial perfusion abnormalities in women with SLE. Arthritis Rheum 1997;40:S219.
25. Hosenpud JD, Montanaro A, Hart MV et al. Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am J Med 1984;77:286-92.
26. Woford JL, Kahl FR, Howard GR, McKinney WM, Toole JF, Crouse JR. Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb 1991;11:1786-94.
27. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725 [letter].
28. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum 1999;42:1309-11.
29. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. The Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
30. Vitali C, Bencivelli W, Isenberg DA et al. Disease activity in systemic lupus erythematosus: Report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use for the development of an activity score. The European Consensus Study Group for Disease Activity in SLE. Clin Exp Rheumatol 1992;10:541-7.
31. Gladman D, Glizler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/ American College of Rheumatology Damage Index for Systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
32. Ghavari AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann Rheum Dis 1987;46:1-6.
33. Brandt JT, Barna LK, Triplett DA. Laboratory identification of lupus anticoagulants: Results of The Second International Workshop for identification of lupus anticoagulants. Thromb Haemost 1995; 74:1597-603.
34. Manzi S, Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Rairie J, Tracy RP, Kuller LH. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Artrhitis Rheum 1999; 42:51-60.
35. Svenungsson E, Jensen-Urstad K, Heimbürger M et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 2001;104:1887-93.
36. Falaschi F, Ravelli A, Martignoli A et al. Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2000;43:1405-9.
37. Doria A, Shonenfeld Y, Wu R et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003;62:1071-7.
38. Roman MJ, Shanker BA, Davis A et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406.
39. Selzer F, Sutton-Tyrrell K, Fitzgerald SG, Pratt JE, Tracy RP, Kuller LH, Manzi S. Comparison of risk factors for vascular disease in the carotid and aorta in women with systemic lupus erythematosus. Arthritis Rheum 2004;50:151-9.
40. Ames PRJ, Mararita A, Delgado Alvers J, Tominasino C, Iannaccone L, Brancaccio V. Anticardiolipin antibody titre and plasma homocysteine level independently predict intima-media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies. Lupus 2002;11:208-14.
41. Medina G, Casaos D, Jara LJ, Vera-Lastra O, Fuentes M, Barite L. Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 2003;62:607-10.
42. Petri M, Spence D, Bone LR, Hochberg MC. Coronary artery disease risk factors in the Johns Hopkins Cohort: Prevalence, recognition by patients and preventive practices. Medicine (Baltimore) 1992; 71:291-302.
43. Borba EF, Bonfa E. Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity and anticardiolipin antibodies. Lupus 1997;6:533-9.
44. Bulkeley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induces in it by corticoid therapy. A study of 36 necropsy patients. Am J Med 1975;58:243-64.
45. Manzi S, Meilhan EN, Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham study. Am J Epidemiol 1997;145:408-15.